• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCAMP4 Therapeutics
    Picture of CAMP4 Therapeutics logo

    CAMP — CAMP4 Therapeutics News Story

    $3.300.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    • Market Cap
      $207.09m
    • Enterprise Value
      $120.69m
    • Revenue
      $3.50m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CAMP Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CAMP Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:47 PM

    Picture of CAMP4 Therapeutics logoCAMP4 Therapeutics
    09/03/2026 16:47
    NASDAQ TRADE HALT  CAMP.O  VOLATILITY TRADING PAUSE AT 12:47 PM
    

    Recent news on CAMP4 Therapeutics

    See all news
    • Brief: Camp4 Therapeutics Receives Authorization In The United Kingdom For Phase 1/2 Human Clinical Trial Of Cmp-002 In Patients With Syngap1-Related Disorder

      10/09/2026 12:50
    • Camp4 Therapeutics Corp Reports Results For The Quarter Ended June 30: Earnings Summary

      13/08/2026 22:06
    • Camp4 Therapeutics Q2 Loss Per Share Misses Estimates On Non: cash derivative charge

      13/08/2026 21:22
    • Camp4 Therapeutics Corp Expected To Post A Loss Of 21 Cents A Share: Earnings Preview

      10/08/2026 12:51
    • U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation

      16/06/2026 09:11

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.